Alpha-Synuclein and Cognitive Decline in Parkinson Disease

Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment is one of the most disabling non-motor symptoms t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tian-Sin Fan, Sam Chi-Hao Liu, Ruey-Meei Wu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/c76dc22c2cfb48288f6dac28ad722335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c76dc22c2cfb48288f6dac28ad722335
record_format dspace
spelling oai:doaj.org-article:c76dc22c2cfb48288f6dac28ad7223352021-11-25T18:11:28ZAlpha-Synuclein and Cognitive Decline in Parkinson Disease10.3390/life111112392075-1729https://doaj.org/article/c76dc22c2cfb48288f6dac28ad7223352021-11-01T00:00:00Zhttps://www.mdpi.com/2075-1729/11/11/1239https://doaj.org/toc/2075-1729Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment is one of the most disabling non-motor symptoms that occurs during the progression of the disease. The accumulation and spreading of alpha-synuclein pathology from the brainstem to limbic and neocortical structures is correlated with emerging cognitive decline in PD. This review summarizes the genetic and pathophysiologic relationship between alpha-synuclein and cognitive impairment in PD, together with potential areas of biomarker advancement.Tian-Sin FanSam Chi-Hao LiuRuey-Meei WuMDPI AGarticleParkinson diseasealpha-synucleincognitiondementianon-motor symptomLewy bodyScienceQENLife, Vol 11, Iss 1239, p 1239 (2021)
institution DOAJ
collection DOAJ
language EN
topic Parkinson disease
alpha-synuclein
cognition
dementia
non-motor symptom
Lewy body
Science
Q
spellingShingle Parkinson disease
alpha-synuclein
cognition
dementia
non-motor symptom
Lewy body
Science
Q
Tian-Sin Fan
Sam Chi-Hao Liu
Ruey-Meei Wu
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
description Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment is one of the most disabling non-motor symptoms that occurs during the progression of the disease. The accumulation and spreading of alpha-synuclein pathology from the brainstem to limbic and neocortical structures is correlated with emerging cognitive decline in PD. This review summarizes the genetic and pathophysiologic relationship between alpha-synuclein and cognitive impairment in PD, together with potential areas of biomarker advancement.
format article
author Tian-Sin Fan
Sam Chi-Hao Liu
Ruey-Meei Wu
author_facet Tian-Sin Fan
Sam Chi-Hao Liu
Ruey-Meei Wu
author_sort Tian-Sin Fan
title Alpha-Synuclein and Cognitive Decline in Parkinson Disease
title_short Alpha-Synuclein and Cognitive Decline in Parkinson Disease
title_full Alpha-Synuclein and Cognitive Decline in Parkinson Disease
title_fullStr Alpha-Synuclein and Cognitive Decline in Parkinson Disease
title_full_unstemmed Alpha-Synuclein and Cognitive Decline in Parkinson Disease
title_sort alpha-synuclein and cognitive decline in parkinson disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c76dc22c2cfb48288f6dac28ad722335
work_keys_str_mv AT tiansinfan alphasynucleinandcognitivedeclineinparkinsondisease
AT samchihaoliu alphasynucleinandcognitivedeclineinparkinsondisease
AT rueymeeiwu alphasynucleinandcognitivedeclineinparkinsondisease
_version_ 1718411522709913600